Rasagiline
Rasagiline is a prescription medication available as oral tablets in 0.5 mg and 1 mg strengths, used to treat symptoms of Parkinson's disease by helping to increase dopamine levels in the brain. It is a generic version manufactured by Chartwell RX, LLC. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Rasagiline is a prescription medication available as oral tablets in 0.5 mg and 1 mg strengths, used to treat symptoms of Parkinson's disease by helping to increase dopamine levels in the brain. It is a generic version manufactured by Chartwell RX, LLC. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Rasagiline", "mediaType": "text/html", "description": " Access the FDA dataset for Rasagiline — ANDA 210150 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210150" } ] |
| identifier | ANDA210150 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "fda", "pharmaceuticals", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Rasagiline |
